We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Research · November 07, 2014

Standard and Adapted Sunitinib Regimen Equivalent in Elderly Patients With Metastatic RCC

Clinical Genitourinary Cancer


Additional Info

Clinical Genitourinary Cancer
Standard vs Adapted Sunitinib Regimen in Elderly Patients With Metastatic Renal Cell Cancer: Results From a Large Retrospective Analysis
Clin Genitourin Cancer 2014 Jun 01;12(3)182-189, U De Giorgi, E Scarpi, C Sacco, M Aieta, G Lo Re, T Sava, C Masini, F De Vincenzo, V Baldazzi, A Camerini, G Fornarini, L Burattini, G Rosti, V Ferrari, L Moscetti, VE Chiuri, S Luzi Fedeli, D Amadori, U Basso

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading